Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Keeping Calm: Benzodiazepines are the most prescribed anxiolytics and are used by a broad population. However, benzodiazepines can cause unwanted side effects, including sedation, development of tolerance, and withdrawal symptoms after long-term administration. Rupprecht et al. (p. 490 ; published online 18 June) now find that a translocator protein (18-kD) ligand, XBD173, is a fast-acting anxiolytic agent, both in animals and humans, which lacks the unwanted side effects of benzodiazepines and provides a promising target for novel clinically effective anxiolytic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives
Rupprecht, R., & Holsboer, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01399-5 · Cited by 633
Self-citationBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 457
Patchev, V. K., Shoaib, M., Holsboer, F., & Almeida, O. F. X. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90330-1 · Cited by 306
Self-citation
Research works printed but not linked: 1
- Zwanzger P., Rupprecht R., J. Psychiatry Neurosci. 30, 167 (2005).15944741
Cited by
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
Self-citationExtrasynaptic GABAA Receptors: Their Function in the CNS and Implications for Disease
Brickley, S. G., & Mody, I. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.012 · Cited by 676
The GABA system in anxiety and depression and its therapeutic potential
Möhler, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.040 · Cited by 590
(2010) · Progress in Brain Research · doi:10.1016/b978-0-444-53630-3.00008-7 · Cited by 584
Evidence for brain glial activation in chronic pain patients
Loggia, M. L., Chonde, D. B., Akeju, O., Arabasz, G., Catana, C., Edwards, R. R., Hill, E., Hsu, S., Izquierdo-Garcia, D., Ji, R.-R., et al. (2015) · Brain · doi:10.1093/brain/awu377 · Cited by 503
Stress Hormone Regulation: Biological Role and Translation into Therapy
Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473
“The importance of neuroactive steroids signaling has been recently demonstrated in a study that used the drug candidate XBD173 as a tool (Rupprecht et al. 2009).”
BackgroundInfluentialSelf-citationWang, Y.-L., Han, Q.-Q., Gong, W.-Q., Pan, D.-H., Wang, L.-Z., Hu, W., Yang, M., Li, B., Yu, J., & Liu, Q. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1054-3 · Cited by 438
A key role for orexin in panic anxiety
Johnson, P. L., Truitt, W., Fitz, S. D., Minick, P. E., Dietrich, A., Sanghani, S., Träskman-Bendz, L., Goddard, A. W., Brundin, L., & Shekhar, A. (2010) · Nature Medicine · doi:10.1038/nm.2075 · Cited by 414
50 years of hurdles and hope in anxiolytic drug discovery
Griebel, G., & Holmes, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4075 · Cited by 414
Schumacher, M., Mattern, C., Ghoumari, A., Oudinet, J. P., Liere, P., Labombarda, F., Sitruk-Ware, R., De Nicola, A. F., & Guennoun, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 355
Self-citationBandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190867 · Cited by 347
“Thus, TSPO ligands are promising candidates for novel anxiolytic drugs (Rupprecht et al. 2009), though a polymorphism of the binding site exists in humans that means around 10% have a low affinity variant (Owen et al. 2011).”
BackgroundRudolph, U., & Möhler, H. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135947 · Cited by 319
The age of anxiety: role of animal models of anxiolytic action in drug discovery
Cryan, J. F., & Sweeney, F. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01362.x · Cited by 316
The role of allopregnanolone in depression and anxiety
Schüle, C., Nothdurfter, C., & Rupprecht, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.003 · Cited by 312
Self-citationInhibition in the amygdala anxiety circuitry
Babaev, O., Piletti Chatain, C., & Krueger-Burg, D. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0063-8 · Cited by 308
Structure of the Mitochondrial Translocator Protein in Complex with a Diagnostic Ligand
Jaremko, Ł., Jaremko, M., Giller, K., Becker, S., & Zweckstetter, M. (2014) · Science · doi:10.1126/science.1248725 · Cited by 259
Role of mitochondria in steroidogenesis
Papadopoulos, V., & Miller, W. L. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.05.002 · Cited by 251
Carver, C. M., & Reddy, D. S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3276-5 · Cited by 248
Positron emission tomography and functional characterization of a complete PBR/TSPO knockout
Banati, R. B., Middleton, R. J., Chan, R., Hatty, C. R., Wai-Ying Kam, W., Quin, C., Graeber, M. B., Parmar, A., Zahra, D., Callaghan, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6452 · Cited by 241
Progesterone Synthesis in the Nervous System: Implications for Myelination and Myelin Repair
Schumacher, M., Hussain, R., Gago, N., Oudinet, J.-P., Mattern, C., & Ghoumari, A. M. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00010 · Cited by 217
Self-citationKarlstetter, M., Nothdurfter, C., Aslanidis, A., Moeller, K., Horn, F., Scholz, R., Neumann, H., Weber, B. H. F., Rupprecht, R., & Langmann, T. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-3 · Cited by 216
Self-citationThe 18 kDa Translocator Protein, Microglia and Neuroinflammation
Liu, G., Middleton, R. J., Hatty, C. R., Kam, W. W., Chan, R., Pham, T., Harrison‐Brown, M., Dodson, E., Veale, K., & Banati, R. B. (2014) · Brain Pathology · doi:10.1111/bpa.12196 · Cited by 211
Vanhee, C., Zapotoczny, G., Masquelier, D., Ghislain, M., & Batoko, H. (2011) · The Plant Cell · doi:10.1105/tpc.110.081570 · Cited by 204
Descalzi, G., Mitsi, V., Purushothaman, I., Gaspari, S., Avrampou, K., Loh, Y.-H. E., Shen, L., & Zachariou, V. (2017) · Science Signaling · doi:10.1126/scisignal.aaj1549 · Cited by 188
Neurosteroids, stress and depression: Potential therapeutic opportunities
Zorumski, C. F., Paul, S. M., Izumi, Y., Covey, D. F., & Mennerick, S. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.005 · Cited by 194
Ikawa, M., Lohith, T. G., Shrestha, S., Telu, S., Zoghbi, S. S., Castellano, S., Taliani, S., Da Settimo, F., Fujita, M., Pike, V. W., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178996 · Cited by 195
Cellular sources of TSPO expression in healthy and diseased brain
Nutma, E., Ceyzériat, K., Amor, S., Tsartsalis, S., Millet, P., Owen, D. R., Papadopoulos, V., & Tournier, B. B. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05166-2 · Cited by 192
Molecular imaging of microglia/macrophages in the brain
Venneti, S., Lopresti, B. J., & Wiley, C. A. (2013) · Glia · doi:10.1002/glia.22357 · Cited by 189
Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism
Gut, P., Baeza-Raja, B., Andersson, O., Hasenkamp, L., Hsiao, J., Hesselson, D., Akassoglou, K., Verdin, E., Hirschey, M. D., & Stainier, D. Y. R. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1136 · Cited by 182
Neurosteroids: Endogenous allosteric modulators of GABAA receptors
Lambert, J. J., Cooper, M. A., Simmons, R. D. J., Weir, C. J., & Belelli, D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.009 · Cited by 180
Richards, E. M., Zanotti-Fregonara, P., Fujita, M., Newman, L., Farmer, C., Ballard, E. D., Machado-Vieira, R., Yuan, P., Niciu, M. J., Lyoo, C. H., et al. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0401-9 · Cited by 180
Porcu, P., Barron, A. M., Frye, C. A., Walf, A. A., Yang, S. ‐., He, X. ‐., Morrow, A. L., Panzica, G. C., & Melcangi, R. C. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12351 · Cited by 171
Hachez, C., Veljanovski, V., Reinhardt, H., Guillaumot, D., Vanhee, C., Chaumont, F., & Batoko, H. (2014) · The Plant Cell · doi:10.1105/tpc.114.134080 · Cited by 154
Ligand for Translocator Protein Reverses Pathology in a Mouse Model of Alzheimer's Disease
Barron, A. M., Garcia-Segura, L. M., Caruso, D., Jayaraman, A., Lee, J.-W., Melcangi, R. C., & Pike, C. J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1350-13.2013 · Cited by 152
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response
Gunn, B. G., Cunningham, L., Mitchell, S. G., Swinny, J. D., Lambert, J. J., & Belelli, D. (2015) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.06.001 · Cited by 149
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
Schüle, C., Eser, D., Baghai, T. C., Nothdurfter, C., Kessler, J. S., & Rupprecht, R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.025 · Cited by 150
Self-citationLeydig cell aging and hypogonadism
Beattie, M. C., Adekola, L., Papadopoulos, V., Chen, H., & Zirkin, B. R. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.02.014 · Cited by 139
The emergence of new psychoactive substance (NPS) benzodiazepines: A review
Manchester, K. R., Lomas, E. C., Waters, L. J., Dempsey, F. C., & Maskell, P. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2211 · Cited by 150
Determination of [11C]PBR28 Binding Potential in vivo: A First Human TSPO Blocking Study
Owen, D. R., Guo, Q., Kalk, N. J., Colasanti, A., Kalogiannopoulou, D., Dimber, R., Lewis, Y. L., Libri, V., Barletta, J., Ramada-Magalhaes, J., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.46 · Cited by 133
Locci, A., & Pinna, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13843 · Cited by 132
Modulation of three key innate immune pathways for the most common retinal degenerative diseases
Akhtar‐Schäfer, I., Wang, L., Krohne, T. U., Xu, H., & Langmann, T. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708259 · Cited by 129
Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis
Papadopoulos, V., Aghazadeh, Y., Fan, J., Campioli, E., Zirkin, B., & Midzak, A. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.03.014 · Cited by 127
The changing landscape in translocator protein (TSPO) function
Selvaraj, V., & Stocco, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.02.007 · Cited by 126
Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies
Midzak, A., & Papadopoulos, V. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00106 · Cited by 114
The rise of a new GABA pharmacology
Möhler, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.020 · Cited by 119
Scholz, R., Caramoy, A., Bhuckory, M. B., Rashid, K., Chen, M., Xu, H., Grimm, C., & Langmann, T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0422-5 · Cited by 111
“Specific TSPO ligands are also under investigation as treatment options for neurological disorders including Alzheimer’s disease [24], multiple sclerosis [25], neuropathic pain [26], peripheral nerve injury [22], and anxiety disorders [27].”
BackgroundGABA ergic signalling in the immune system
Barragán, A., Weidner, J. M., Jin, Z., Korpi, E. R., & Birnir, B. (2015) · Acta Physiologica · doi:10.1111/apha.12467 · Cited by 119
Neurosteroids and GABAA Receptor Interactions: A Focus on Stress
Gunn, B. G., Brown, A. R., Lambert, J. J., & Belelli, D. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00131 · Cited by 108
Translocator protein (TSPO): the new story of the old protein in neuroinflammation
Lee, Y., Park, Y., Nam, H., Lee, J.-W., & Yu, S.-W. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.273 · Cited by 107
VDAC1 and the TSPO: Expression, Interactions, and Associated Functions in Health and Disease States
Shoshan‐Barmatz, V., Pittala, S., & Mizrachi, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133348 · Cited by 113
Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective
Paul, S. M., Pinna, G., & Guidotti, A. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100215 · Cited by 106
CAPON-nNOS coupling can serve as a target for developing new anxiolytics
Zhu, L., Li, T., Luo, C., Jiang, N., Chang, L., Lin, Y., Zhou, H.-H., Chen, C., Zhang, Y., Lü, W., et al. (2014) · Nature Medicine · doi:10.1038/nm.3644 · Cited by 109
Fujita, M., Kobayashi, M., Ikawa, M., Gunn, R. N., Rabiner, E. A., Owen, D. R., Zoghbi, S. S., Haskali, M. B., Telu, S., Pike, V. W., et al. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0334-8 · Cited by 104
Role of hormones and neurosteroids in epileptogenesis
Reddy, D. S. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00115 · Cited by 115
Recent advances in graphene/polyamide 6 composites: a review
Fu, X., Yao, C., & Yang, G. (2015) · RSC Advances · doi:10.1039/c5ra09312k · Cited by 112
Hassan, W., Barroso Silva, C., Mohammadzai, I. U., Teixeira da Rocha, J., & Landeira-Fernandez, J. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120232135 · Cited by 100
“Cholecystokinin-4-induced panic attacks are an established and reliable model of human anxiety in healthy volunteers [75, 78-79].”
Current and Novel Psychopharmacological Drugs for Anxiety Disorders
Bandelow, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9705-0_19 · Cited by 127
GABA and 5-HT systems are implicated in the anxiolytic-like effect of spinosin in mice
Liu, J., Wei-min, Z., Yang, Y., Shi, J., Liu, Q.-T., Guo-lin, L., Fang, N., Li, J., & Guo, J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.003 · Cited by 105
Meyer, L., Patte‐Mensah, C., Taleb, O., & Mensah‐Nyagan, A. G. (2010) · Pain · doi:10.1016/j.pain.2010.10.015 · Cited by 108
Hormones, nicotine, and cocaine: Clinical studies
Mello, N. K. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.10.003 · Cited by 98
Tokuda, K., O'Dell, K. A., Izumi, Y., & Zorumski, C. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4101-10.2010 · Cited by 97
Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder
Pinna, G., & Rasmusson, A. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00256 · Cited by 94
TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis
Owen, D. R., Fan, J., Campioli, E., Venugopal, S., Midzak, A., Daly, E., Harlay, A., Issop, L., Libri, V., Kalogiannopoulou, D., et al. (2017) · Biochemical Journal · doi:10.1042/bcj20170648 · Cited by 93
Agis-Balboa, R. C., Guidotti, A., & Pinna, G. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3567-5 · Cited by 89
Mitochondrial protein import and the genesis of steroidogenic mitochondria
Midzak, A., Rone, M., Aghazadeh, Y., Culty, M., & Papadopoulos, V. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.007 · Cited by 89
Nin, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00073 · Cited by 88
Programming the Brain and Behaviour by Early‐Life Stress: A Focus on Neuroactive Steroids
Brunton, P. J. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12265 · Cited by 87
Zwanzger, P., Domschke, K., & Bradwejn, J. (2012) · Depression and Anxiety · doi:10.1002/da.21919 · Cited by 86
Neurosteroids—Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy
Reddy, D. S., & Rogawski, M. A. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0077 · Cited by 100
Cholesterol-mediated allosteric regulation of the mitochondrial translocator protein structure
Jaipuria, G., Leonov, A., Giller, K., Vasa, S. K., Jaremko, Ł., Jaremko, M., Linser, R., Becker, S., & Zweckstetter, M. (2017) · Nature Communications · doi:10.1038/ncomms14893 · Cited by 89
Reddy, D. S. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00038 · Cited by 90
Neuroendocrine aspects of catamenial epilepsy
Reddy, D. S. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.04.016 · Cited by 87
Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa
Girard, C., Liu, S., Adams, D., Lacroix, C., Sinéus, M., Boucher, C., Papadopoulos, V., Rupprecht, R., Schumacher, M., & Groyer, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02215.x · Cited by 75
Self-citationTSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria
Gatliff, J., & Campanella, M. (2016) · Biochemical Journal · doi:10.1042/bj20150899 · Cited by 84
Pinna, G., & Rasmusson, A. M. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02234.x · Cited by 74
Nothdurfter, C., Rammes, G., Baghai, T. C., Schüle, C., Schumacher, M., Papadopoulos, V., & Rupprecht, R. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02166.x · Cited by 71
Self-citationEndozepines and their receptors: Structure, functions and pathophysiological significance
Tonon, M.-C., Vaudry, H., Chuquet, J., Guillebaud, F., Fan, J., Masmoudi-Kouki, O., Vaudry, D., Lanfray, D., Morin, F., Prevot, V., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.008 · Cited by 71
Lost in translocation: the functions of the 18-kD translocator protein
Gut, P., Zweckstetter, M., & Banati, R. B. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.04.001 · Cited by 70
PET tracers for the peripheral benzodiazepine receptor and uses thereof
Schweitzer, P. J., Fallon, B. A., Mann, J. J., & Kumar, J. S. D. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.012 · Cited by 89
Allopregnanolone in mood disorders: Mechanism and therapeutic development
Chen, S., Gao, L., Li, X., & Ye, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105682 · Cited by 75
Reddy, D. S., & Rogawski, M. A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02870.x · Cited by 69
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy
Costa, B., Pozzo, E. D., Giacomelli, C., Barresi, E., Taliani, S., Settimo, F. D., & Martini, C. (2016) · Scientific Reports · doi:10.1038/srep18164 · Cited by 80
Gong, J., Szego, É. M., Leonov, A., Benito, E., Becker, S., Fischer, A., Zweckstetter, M., Outeiro, T., & Schneider, A. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2070-18.2019 · Cited by 66
Kobayashi, M., Jiang, T., Telu, S., Zoghbi, S. S., Gunn, R. N., Rabiner, E. A., Owen, D. R., Guo, Q., Pike, V. W., Innis, R. B., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17699223 · Cited by 65
Animal models of post-traumatic stress disorder and novel treatment targets
Aspesi, D., & Pinna, G. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000467 · Cited by 64
Neuroscience-driven discovery and development of sleep therapeutics
Dresler, M., Spoormaker, V. I., Beitinger, P., Czisch, M., Kimura, M., Steiger, A., & Holsboer, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.012 · Cited by 63
Self-citationAghazadeh, Y., Zirkin, B. R., & Papadopoulos, V. (2015) · Vitamins and hormones · doi:10.1016/bs.vh.2014.12.006 · Cited by 74
Raber, J., Arzy, S., Bertolus, J. B., Depue, B., Haas, H. E., Hofmann, S. G., Kangas, M., Kensinger, E., Lowry, C. A., Marusak, H. A., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.015 · Cited by 62
Neurosteroids and their role in sex-specific epilepsies
Reddy, D. S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.010 · Cited by 71
Rupprecht, R., Wetzel, C. H., Dorostkar, M. M., Herms, J. W., Albert, N. L., Schwarzbach, J. V., Schumacher, M., & Neumann, I. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01561-3 · Cited by 73
Self-citationZhang, L., Zhao, N., Guo, W.-Z., Jin, Z., Qiu, Z.-K., Chen, H., Xue, R., Zhang, Y., Yang, R., & Li, Y. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.016 · Cited by 65
Johnson, P. L., Federici, L. M., & Shekhar, A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.027 · Cited by 61
Zhang, J., Cai, C.-Y., Wu, H., Zhu, L., Luo, C., & Zhu, D. (2016) · Scientific Reports · doi:10.1038/srep29551 · Cited by 65
Neurosteroid regulation of GABAA receptors: A role in catamenial epilepsy
Joshi, S., & Kapur, J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.031 · Cited by 66
Schaeffer, V., Meyer, L., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.009 · Cited by 73
TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis
Lejri, I., Grimm, A., Hallé, F., Abarghaz, M., Klein, C., Maître, M., Schmitt, M., Bourguignon, J., Mensah‐Nyagan, A. G., Bihel, F. J. ‐., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190127 · Cited by 68
Qiu, Z.-K., Zhang, L., Zhao, N., Chen, H., Zhang, Y., Liu, Y., Mi, T., Zhou, W., Li, Y., Yang, R., et al. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.010 · Cited by 61
Miao, Y.-L., Guo, W.-Z., Shi, W., Fang, W.-W., Liu, Y., Liu, J., Li, B., Wu, W., & Li, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101450 · Cited by 58
Role of Mitochondria in Steroidogenesis
Miller, W. L. (2011) · Endocrine Development · doi:10.1159/000321204 · Cited by 57
Metadata
- Authors
- Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., Uzunov, V., McAllister, K. H., Bertaina-Anglade, V., La Rochelle, C. D., Tuerck, D., Floesser, A., Kiese, B., Schumacher, M., Landgraf, R., Holsboer, F., & Kucher, K.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Ludwig-Maximilians-Universität München (DE)
- Novartis Institutes for BioMedical Research (CH)
- Novartis Institute for Biomedical Research (NIBR), Neuroscience, 4056 Basel, Switzerland.
- Biotrial, 3500 Rennes, France.
- F. Hoffmann-La Roche AG (CH)
- Novartis (Switzerland) (CH)
- INSERM UMR 788, and University Paris-Sud 11, 94274 Paris, France.
- Corresponding author
- Rupprecht, Rainer
- Venue
- Science
- Published
- 2009-07-24
- Volume
- 325
- Issue
- 5939
- Pages
- 490-493
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2031094958
- Cited by
- 328
- References
- 28
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 17 · 2023: 10 · 2022: 15 · 2021: 13 · 2020: 21 · 2019: 17 · 2018: 18 · 2017: 20 · 2016: 30 · 2015: 32 · 2014: 29 · 2013: 19 · 2012: 20
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- anxiolytics, benzodiazepine alternatives, neurosteroids, panic attacks, sedation, drug tolerance, withdrawal symptoms
- MeSH terms
- Adult, Alprazolam, Animals, Benzodiazepines, Cell Line, Drug Tolerance, gamma-Aminobutyric Acid, Humans, Isoquinolines, Male, Mice, Inbred C57BL, Purines, Receptors, GABA-A, Substance Withdrawal Syndrome, Tetragastrin, Anti-Anxiety Agents, Panic Disorder, Rats, Sprague-Dawley, Receptors, GABA, Neurotransmitter Agents, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.